President Donald Trump signed an executive order on May 12 directing drugmakers to lower the prices of their medicines so they line up with what other countries pay.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

Any such plan will most likely be subject to challenges in court, and it is not clear whether it will pass legal muster, especially without action by Congress.